文献速递心力衰竭与心肌病心律失常

窄QRS心衰患者的心脏再同步化治疗:EchoCRT试验的交叉相关分析

Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究基于EchoCRT试验,对807例窄QRS心衰患者用组织多普勒交叉相关分析评估机械激动延迟,发现46%无延迟者接受CRT增加不良结局风险(HR 1.70),CRT组新发延迟亦与事件增加相关。

要点

  • 窄QRS心衰患者中近半数无机械激动延迟,此类患者CRT可能有害。
  • 无延迟者接受CRT增加心衰住院或死亡风险(HR 1.70)。
  • CRT组新发机械激动延迟与不良事件风险升高相关(HR 3.73)。

核心结论

  • 在EchoCRT人群中,交叉相关分析缺乏机械激动延迟与不良结局显著相关,可能与CRT起搏后新发延迟有关。

研究设计与样本

  • 基于EchoCRT试验的事后分析,807例窄QRS心衰患者可完成基线组织多普勒交叉相关分析。

主要发现

  • 807例中375例(46%)无基线机械激动延迟。
  • 无延迟者中CRT-On较CRT-Off不良结局风险增加(HR 1.70,95%CI 1.13-2.55,p=0.01),交互作用p=0.04。
  • 配对数据无事件患者(n=541)中,CRT-On组新发延迟者不良事件风险增加(HR 3.73,95%CI 1.15-12.14,p=0.03)。

关键数值与推荐

  • 机械激动延迟定义为预设最大激动延迟≥35 ms。
  • 研究结局为心衰住院或死亡。

临床怎么用

  • 窄QRS心衰患者接受CRT前应评估机械激动延迟,无延迟者不宜行CRT。
  • CRT治疗中需关注新发机械激动延迟,其与不良事件风险升高相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cross correlation analysis (CCA) using tissue Doppler imaging has been shown to be associated with outcome after cardiac resynchronization therapy (CRT) in patients with heart failure (HF) with wide QRS. However, its significance in patients with narrow QRS treated with CRT is unknown. OBJECTIVES: The aim of the current study was to investigate the association of mechanical activation delay by CCA with study outcome in patients with HF enrolled in the EchoCRT trial. METHODS: Baseline CCA could be performed from tissue Doppler imaging in the apical views in 807 of 809 (99.7%) enrolled patients, and 6-month follow-up could be performed in 610 of 635 (96%) patients with available echocardiograms. Patients with a pre-specified maximal activation delay ≥35 ms were considered to have significant delay. The study outcome was HF hospitalization or death. RESULTS: Of 807 patients, 375 (46%) did not have delayed mechanical activation at baseline by CCA. Patients without delayed mechanical activation who were randomized to CRT-On compared with CRT-Off had an increased risk of poor outcome (hazard ratio: 1.70; 95% confidence interval: 1.13 to 2.55; p = 0.01) with a significant interaction term (p = 0.04) between delayed mechanical activation and device randomization for the endpoint. Among patients with paired baseline and follow-up data with no events before 6-month follow-up (n = 541), new-onset delayed mechanical activation in the CRT-On group showed a significant increase in unfavorable events (hazard ratio: 3.73; 95% confidence interval: 1.15 to 12.14; p = 0.03). CONCLUSIONS: In the EchoCRT population, absence of delayed mechanical activation by CCA was significantly associated with poor outcomes, possibly due to the onset of new delayed mechanical activation with CRT pacing. (Echocardiography Guided Cardiac Resynchronization Therapy [EchoCRT] Trial; NCT00683696).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Tayal B, Gorcsan J, Bax JJ, et al. Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes. J Am Coll Cardiol. 2018. PMID: 29566816. doi:10.1016/j.jacc.2018.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。